Scaffold attachment region-containing retrovirus vectors improve long-term proviral expression after transplantation of GFP-modified CD34+ baboon repopulating cells

被引:26
作者
Kurre, P
Morris, J
Thomasson, B
Kohn, DB
Kiem, HP
机构
[1] Fred Hutchinson Canc Res Ctr, Div Clin Res, Seattle, WA 98109 USA
[2] Univ Washington, Sch Med, Dept Pediat, Seattle, WA 98195 USA
[3] Univ Washington, Sch Med, Dept Med, Seattle, WA 98195 USA
[4] Childrens Hosp Los Angeles, Div Res Immunol, Los Angeles, CA 90027 USA
[5] Univ So Calif, Keck Sch Med, Los Angeles, CA USA
关键词
D O I
10.1182/blood-2003-03-0962
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Sustained high-level proviral expression is important for clinical applications of gene therapy. Genetic elements including the beta-interferon scaffold attachment region (SAR) have been shown to. improve transgene expression in hematopoietic cells. We hypotheisized that SAR elements might improve expression and allow the preselection of successfully transduced cells. Thus, we transplanted green fluorescent protein (GFP)-selected cells, half of which had been transduced with either SAR or non-SAR-containing retrovirus vectors, into 3 animals. All animals showed delayed engraftment compared with historic controls (28 vs 15.5 days). GFP marking was seen at levels up to 8% but declined over the first 6 weeks. Importantly, fluorescence intensity was 2- to 9-fold increased in progeny of SAR versus non-SAR vector-modified cells in all hematopoietic lineages for the duration of follow-up (6-12 months). In conclusion, the use of SAR-containing vectors improved transgene expression in hematopoietic repopulating cells, which may obviate the need for multicopy integration to achieve high-level expression and reduce the risk for insertional mutagenesis. (C) 2003 by The American Society of Hematology.
引用
收藏
页码:3117 / 3119
页数:3
相关论文
共 26 条
[1]   Scaffold attachment region-mediated enhancement of retroviral vector expression in primary T cells [J].
Agarwal, M ;
Austin, TW ;
Morel, F ;
Chen, JY ;
Böhnlein, E ;
Plavec, I .
JOURNAL OF VIROLOGY, 1998, 72 (05) :3720-3728
[2]   An improved vector for high-level, consistent retroviral transgene expression in human thymocytes after competitive reconstitution from transduced peripheral blood stem cells [J].
Austin, TW ;
Moss, K ;
Morel, F ;
Plavec, I .
HUMAN GENE THERAPY, 2001, 12 (10) :1239-1249
[3]   Effect of scaffold attachment region on transgene expression in retrovirus vector-transduced primary T cells and macrophages [J].
Auten, J ;
Agarwal, M ;
Chen, JY ;
Sutton, R ;
Plavec, I .
HUMAN GENE THERAPY, 1999, 10 (08) :1389-1399
[4]  
Bode J, 1995, INT REV CYTOL, V162A, P389
[5]   MULTIPLE MODIFICATIONS IN CIS-ELEMENTS OF THE LONG TERMINAL REPEAT OF RETROVIRAL VECTORS LEAD TO INCREASED EXPRESSION AND DECREASED DNA METHYLATION IN EMBRYONIC CARCINOMA-CELLS [J].
CHALLITA, PM ;
SKELTON, D ;
ELKHOUEIRY, A ;
YU, XJ ;
WEINBERG, K ;
KOHN, DB .
JOURNAL OF VIROLOGY, 1995, 69 (02) :748-755
[6]   A chromatin insulator protects retrovirus vectors from chromosomal position effects [J].
Emery, DW ;
Yannaki, E ;
Tubb, J ;
Stamatoyannopoulos, G .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2000, 97 (16) :9150-9155
[7]   Human hematopoietic stem cells stimulated to proliferate in vitro lose engraftment potential during their S/G2/M transit and do not reenter G0 [J].
Glimm, H ;
Oh, IL ;
Eaves, CJ .
BLOOD, 2000, 96 (13) :4185-4193
[8]   Cell cycle-related changes in repopulating capacity of human mobilized peripheral blood CD34+ cells in non-obese diabetic severe combined immune-deficient mice [J].
Gothot, A ;
van der Loo, JCM ;
Clapp, DW ;
Srour, EF .
BLOOD, 1998, 92 (08) :2641-2649
[9]   Improved expression in hematopoietic and lymphoid cells in mice after transplantation of bone marrow transduced with a modified retroviral vector [J].
Halene, S ;
Wang, LJ ;
Cooper, RM ;
Bockstoce, DC ;
Robbins, PB ;
Kohn, DB .
BLOOD, 1999, 94 (10) :3349-3357
[10]   Highly efficient gene transfer into baboon marrow repopulating cells using GALU pseudotype oncoretroviral vectors produced by human packaging cells [J].
Horn, PA ;
Topp, MS ;
Morris, JC ;
Riddell, SR ;
Kiem, HP .
BLOOD, 2002, 100 (12) :3960-3967